Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Plos Medicine|September 13, 2021
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are neededJ Peter Figueroa, Peter J Hotez, Carolina Batista, et al.
Vaccine|December 18, 2004
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720Michael Walther, Susanna Dunachie, Sheila Keating, et al.
Eclinicalmedicine|August 9, 2021
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemicPeter J Hotez, Carolina Batista, Yanis Ben Amor, et al.
Biorxiv : the Preprint Server for Biology|January 15, 2021
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaquesNeeltje van Doremalen, Jyothi N Purushotham, Jonathan E Schulz, et al.
Ebiomedicine|July 2, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and femalesNatalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, et al.
Scientific Reports|November 5, 2022
Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomesNeil Berry, Deborah Ferguson, Sarah Kempster, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trialPedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
Cell Reports|May 4, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccinationZixi Yin, Ji-Li Chen, Yongxu Lu, et al.
Wellcome Open Research|May 6, 2024
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trialMainga Hamaluba, Samuel Sang, Benedict Orindi, et al.
The Journal of Infectious Diseases|June 17, 2016
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAPTommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
Pageof 7